Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome

Kidney International

Volumn 50, Issue 1, 1996, Pages 304-311

  Naito, Ichiro ^b   Kawai, Shinichiro ^a   Nomura, Shinsuke ^b   Sado, Yoshikazu ^b   Osawa, Gengo ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ADOLESCENT; ADULT; ALPORT SYNDROME; ARTICLE; BOWMAN MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; GENE MUTATION; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; X CHROMOSOME LINKAGE;

EID: 0029787566     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.316     Document Type: Article

References (43)

1. ALPORT AC: Hereditary familial congenital haemorrhagic nephritis. Brit Med J 1:504-506, 1927
2. FLINTER F, CAMERON J, CHANTLER C, HOUSTON I, BOBROW M: Genetics of classic Alport syndrome. Lancet 2:1005-1007, 1998
3. ATKIN CL, HASSTEDT SJ, MENLOVE L, CANNON L, KIRSCHNER N, SCHWARTZ C, NGUYEN K, SKOLNICK M: Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 42:249-255, 1988
4. HASSTEDT SJ, ATKIN CL, SAN JAJ: Genetic heterogeneity among kindreds with Alport syndrome. Am J Hum Genet 38:940-953, 1986
5. FEINGOLD J, BOIS E, CHOMPRET A, BROYER M, GUBLER MC, GRUNFELD JP: Genetic heterogeneity of Alport syndrome. Kidney Int 27:672-677, 1985
6. BRUNNER H, SCHPODER C, BENNEKOM C, LAMBERMON E, TUERLINGS J, MENZEL D, OLBING H, MONNENS L, WIERINGA B, ROPERS H: Localization of the gene for X-linked Alport's syndrome. Kidney Int 34:507-510, 1988
7. FLINTER FA, ABBS S, BOBROW M: Localization of the gene for classic Alport syndrome. Genomics 4:335-338, 1989
8. SZPIRO-TAPIA S, BOBRIE G, GUILLOUD-BATAILLE M, HEUERTZ S, JULIER C, FREZAL J, GRUNFELD J, HORS-CAYLA M: Linkage studies in X-linked Alport's syndrome. Hum Genet 81:85-87, 1998
9. HOSTIKKA SL, EDDY RL, BYERS MG, HOYHTYA M, SHOWS TB, TRYGGVASON K: Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 87:1606-1610, 1990
10. ZHOU J, BARKER DF, HOSTIKKA SL, GREGORY MC, ATKIN CL, TRYGGVASON K: Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 9:10-18, 1991
11. BARKER DF, HOSTIKKA SL, ZHOU J, CHOW LT, OLIPHANT AR, GERKEN SC, GREGORY MC, SKOLNICK MH, ATKIN CL, TRYGGVASON K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990
12. NOMURA S, OSAWA G, SAI T, HARANO T, HARANO K: A splicing mutation in the alpha 5(IV) collagen gene of a family with Alport's syndrome. Kidney Int 43:1116-1124, 1993
13. NAKAZATO H, HATTORI S, MATSUURA T, KOITABASHI Y, ENDO F, MATSUDA I: Identification of a single base insertion in the COL4A5 gene in Alport syndrome. Kidney Int 44:1091-1096, 1993
14. KAWAI S, NOMURA S, HARANO T, HARANO K, FUKUSHIMA T, OSAWA G, JAPANESE ALPORT NETWORK (JAN): The COL4A5 gene in Japanese Alport syndrome patients: Spectrum of mutations of all exons. Kidney Int 49:814-822, 1996
15. KAWAI S, NOMURA S, HARANO T, HARANO K, FUKUSHIMA T, WAGO M, SHIMIZU B, OSAWA G: A single base mutation in exon 31 converting glycine 852 to arginine in the collagenous domain in an Alport syndrome patient. Nephron (in press)
16. HUDSON BG, REEDERS ST, TRYGGVASON K: Type IV collagen: Structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 268:26033-26036, 1993
17. OOHASHI T, SUGIMOTO M, MATTEI MG, NINOMIYA Y: Identification of a new collagen IV chain, alpha 6(IV), by cDNA isolation and assignment of the gene to chromosome Xq22. which is the same locus for COL4A5. J Biol Chem 269:7520-7526, 1994
18. ZHOU J, DING M, ZHAO ZH, REEDERS ST: Complete primary structure of the sixth chain of human basement membrane collagen, alpha 6(IV) - Isolation of the cDNAs for alpha 6(IV) and comparison with five other type IV collagen chains. J Biol Chem 269:13193-13199, 1994
19. ZHOU J, HERTZ JM, LEINONEN A, TRYGGVASON K: Complete amino acid sequence of the human alpha 5 (IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient. J Biol Chem 267:12475-12481, 1992
20. JOHANSSON C, BUTKOWSKI R, WIESLANDER J: The structural organization of type IV collagen. Identification of three NC1 populations in the glomerular basement membrane. J Biol Chem 267:24533-24537, 1992
21. TIMPL R, WIEDEMANN H, VAN DELDEN V, FURTHMAYR H, KUHN K: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 120:203-211, 1981
22. NAITO I, INOUE S, KAGAWA M, KISHIRO Y, SADO Y, SUGIHARA K, TAKI M, OHMORI H, NINOMIYA Y: Antigen retrieval of type IV collagen alpha chains in paraffin-embedded renal sections from Alport syndrome patients, (abstract) Proceedings of the XIII International Congress of Nephrology, Madrid, July 8, 1995
23. KINOSHITA Y, OSAWA G, MORITA T, KOBAYASHI N, WADA J: Hereditary chronic nephritis (Alport) complicated by nephrotic syndrome. Light, fluorescent and electronmicroscopic studies of renal biopsy specimens. Acta Med Biol Niigata 17:101-117, 1969
24. ATKIN CL, GREGORY MC: Alport syndrome, in Diseases of the Kidney (5th ed), edited by SCHRIER RW, GOTTSCHALK CW, Boston, Little Brown and Co., 1993, pp 571-591
25. SADO Y, KAGAWA M, KISHIRO Y, SUGIHARA K, NAITO I, SEYER J, SUGIMOTO M, OOHASHI T, NINOMIYA Y: Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen. Histochem Cell Biol 104:267-275, 1995
26. SADO Y, KAGAWA M, RAUF S, NAITO I, MORITOH C, OKIGAKI T: Isologous monoclonal antibodies can induce anti-GBM glomerulonephritis in rats. J Pathol 168:221-227, 1992
27. YOSHIOKA K, MICHAEL AF, VELOSA J, FISH AJ: Detection of hidden nephritogenic antigen determinants in human renal and non-renal basement membranes. Am J Pathol 121:156-165, 1985
28. NINOMIYA Y, KAGAWA M, IYAMA K, NAITO I, KISHIRO Y, SEYER J, SUGIMOTO M, OOHASHI T, SADO Y: Differential expression of two basement membrane collagen gene. COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 130:1219-1229, 1995
29. GUBLER MC, ANTIGNAC C, DESCHENES G, KNEBELMANN B, HORS CM, GRUNFELD JP, BROYER M, HABIB R: Genetic, clinical, and morphologic heterogeneity in Alport's syndrome. Adv Nephrol Necker Hosp 22:15-35, 1993
30. KASHTAN C, FISH AJ, KLEPPEL M, YOSHIOKA K, MICHAEL AF: Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 78:1035-1044, 1986
31. NAKANISHI K, YOSHIKAWA N, IIJIMA K, KITAGAWA K, NAKAMURA H, ITO H, YOSHIOKA K, KAGAWA M, SADO Y: Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 46:1413-1421, 1994
32. ANTIGNAC C, KNEBELMANN B, DROUOT L, GROS F, DESCHENES G, HORSCAYLA MC, ZHOU J, TRYGGVASON K, GRUNFELD JP, BROYER M, GUBLER MC: Deletions in the COL4A5 collagen gene in x-linked Alport syndrome - Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. J Clin Invest 93:1195-1207, 1994
33. GUBLER M, KNEBELMANN B, BEZIAU A, BROYER M, PIRSON Y, HADDOUM F, KLEPPEL M, ANTIGNAC C: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142-1147, 1995
34. DING J, ZHOU J, TRYGGVASON K, KASHLAN CE: COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5:161-168, 1994
35. REEDERS S: Molecular genetics of hereditary nephritis. Kidney Int 42:783-792, 1992
36. KASHTAN CE, KLEPPEL MM, BUTKOWSKI RJ, MICHAEL AF, FISH AJ: Alport syndrome, basement membranes and collagen. Pediatr Nephrol 4:523-532, 1990
37. ANTIGNAC C: Molecular genetics of basement membranes: The paradigm of Alport syndrome. Kidney Int 47(Suppl 49):S29-S33, 1995
38. FRANCOMANO C: Key role for a minor collagen. Nature Genet 9:6-8, 1995
39. TRYGGVASON K, ZHOU J, HOSTIKKA SL, SHOWS TB: Molecular genetics of Alport syndrome. Kidney Int 43:38-44, 1993
40. VOGEL B, DOELZ R, KADLER K, HOJIMA Y, ENGEL J, PROCKOP D: A substitution of cysteine for glycine 748 of the a1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away. J Biol Chem 263:19249-19255, 1988
41. WALLIS G, STARMAN B, SCHWARTZ M, BYERS P: Substitution of arginine for glycine at position 847 in the triple helical domain of the alphal(I) chain of type I collagen produces lethal Osteogenesis Imperfecta. J Biol Chem 265:18628-18633, 1990
42. WESTERHAUSEN A, KISHI J, PROCKOP D: Mutations that substitute serine for glycine alpha 1-598 and glycine alpha 1-631 in type I procollagen. J Biol Chem 265:13995-14000, 1990
43. NOMURA S, KAWAI S, NAITO I, SADO Y, OSAWA G: Alport syndrome, from molecular genetics to the patients, in Recent Advances in Molecular Nephrology, edited by ARAKAWA M, NAKAGAWA Y, Niigata, Kohko-Do, Japan, 1995, pp 37-48